Refine
Has Fulltext
- yes (16)
Is part of the Bibliography
- yes (16)
Year of publication
Document Type
- Journal article (15)
- Doctoral Thesis (1)
Language
- English (16)
Keywords
- echocardiography (6)
- prognosis (3)
- amyloidosis (2)
- cardiomyopathy (2)
- cardiovascular magnetic resonance (2)
- deformation (2)
- ejection fraction (2)
- left ventricular hypertrophy (2)
- myocardial infarction (2)
- therapy (2)
- 2-dimensional speckle tracking (1)
- ASE formula (1)
- Anderson-Fabry Disease (1)
- Cardiovascular magnetic-resonance (1)
- Chronic heart-failure (1)
- Coronary artery disease (1)
- D313Y genotype (1)
- Enzyme replacement therapy (1)
- Fabry cardiomyopathy (1)
- Fabry nephropathy (1)
- Fabry-associated pain (1)
- Gewebedoppler (1)
- Guidelines (1)
- Hypertrophic cardiomyopathy (1)
- Impella (1)
- Management (1)
- Manifestation (1)
- Myocardial fibrosis (1)
- Non-Compaction Kardiomyopathie (1)
- Non‐ischaemic cardiogenic shock (1)
- Prevalence (1)
- Prognostic impact (1)
- Risk-factors (1)
- Septal bulge (1)
- Speckle tracking (1)
- Task force (1)
- Teichholz formula (1)
- Ultraschallkardiographie (1)
- Valvular heart-desease (1)
- Ventricular-arrhythmias (1)
- aneurysm (1)
- aortic valve stenosis (AS) (1)
- biomarker (1)
- blood pressure monitoring (1)
- bull’s eye plot (1)
- calcium imaging (1)
- cardiac amyloidosis (1)
- cardiac transplantation (1)
- case report (1)
- chronic thromboembolic pulmonary hypertension (1)
- clinical manifestations (1)
- death rates (1)
- diagnosis (1)
- diagnostic medicine (1)
- diastolic dysfunction (1)
- disease (1)
- dobutamine stress echocardiography (1)
- fabry disease (1)
- fibrosis (1)
- heart disease (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- hemodialysis (1)
- hypertension (1)
- identification (1)
- impact (1)
- inherited metabolic disorders (1)
- left ventricular mass index (1)
- left ventricular non-compaction (1)
- left ventricular thrombusv (1)
- low-gradient AS (1)
- mild (1)
- mortality (1)
- myocardial fibrosis (1)
- pseudo-severe AS (1)
- regression analysis (1)
- right ventricular dysfunction (1)
- speckle tracking (1)
- speckle tracking imaging (1)
- statins (1)
- stem cell transplantation (1)
- tricuspid pressure gradient (1)
- troponin T (1)
Institute
- Medizinische Klinik und Poliklinik I (15)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (7)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (4)
- Medizinische Klinik und Poliklinik II (3)
- Institut für Pharmakologie und Toxikologie (1)
- Neurologische Klinik und Poliklinik (1)
- Pathologisches Institut (1)
Aims
The role of diastolic dysfunction (DD) in prognostic evaluation in heart failure (HF) patients with impaired systolic function remains unclear. We investigated the impact of echocardiography-defined DD on survival in HF patients with mid-range (HFmrEF, EF 41–49%) and reduced ejection fraction (HFrEF, EF < 40%).
Methods and results
A total of 2018 consecutive hospitalized HF patients were retrospectively included and divided in two groups based on baseline EF: HFmrEF group (n = 951, aged 69 ± 13 years, 74.2% male) and HFrEF group (n = 1067, aged 68 ± 13 years, 76.3% male). Clinical data were collected and analysed. All patients completed ≥1 year clinical follow-up. The primary endpoint was defined as all-cause death (including heart transplantation) and cardiovascular (CV)-related death. All-cause mortality (30.8% vs. 24.9%, P = 0.003) and CV mortality (19.1% vs. 13.5%, P = 0.001) were significantly higher in the HFrEF group than the HFmrEF group during follow-up [median 24 (13–36) months]. All-cause mortality increased in proportion to DD severity (mild, moderate, and severe) in either HFmrEF (17.1%, 25.4%, and 37.0%, P < 0.001) or HFrEF (18.9%, 30.3%, and 39.2%, P < 0.001) patients. The risk of all-cause mortality [hazard ratio (HR) = 1.347, P = 0.015] and CV mortality (HR = 1.508, P = 0.007) was significantly higher in HFrEF patients with severe DD compared with non-severe DD after adjustment for identified clinical and echocardiographic covariates. For HFmrEF patients, severe DD was independently associated with increased all-cause mortality (HR = 1.358, P = 0.046) but not with CV mortality (HR = 1.155, P = 0.469).
Conclusions
Echocardiography-defined severe DD is independently associated with increased all-cause mortality in patients with HFmrEF and HFrEF.